Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. (Q38486120)
Jump to navigation
Jump to search
scientific article published on 27 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis. |
scientific article published on 27 April 2010 |
Statements
Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis (English)
Seung Hyeok Han
Bong Jun Cho
Yenna Lee
Young Joo Park
Hong Kyu Lee
Dae Suk Han
Young-Bum Kim
Hak C Jang
Kyong Soo Park
27 April 2010